A novel small molecule, designed and synthesised by Indian researchers, has shown promise in targeted killing of cancer cells. The molecule (Disarib) works by binding itself to a protein called BCL2. While BCL2 protein is produced in excess in cancer cells, its expression is almost undetectable in normal cells. ………………………………………. Inside a cell there is always a balance between proteins that promote cell death (apoptosis) and those that suppress cell death.